Literature DB >> 9803971

HIV seropositivity rates in outreach-based counseling and testing services: program evaluation.

W DiFranceisco1, D R Holtgrave, N Hoxie, W J Reiser, R Resenhoeft, S D Pinkerton, J Vergeront.   

Abstract

A common assumption is that outreach-based HIV counseling and testing services reach a clientele with a higher HIV seroprevalence than clinic-based counseling and testing. To examine this assumption, we analyzed Wisconsin's anonymous counseling and testing client records for 62,299 contacts (testing episodes) from 1992 to 1995. Bivariate analysis of counseling and testing service setting (outreach-based or clinic-based) and HIV test results suggested that outreach contacts were 23% (odds ratio [OR], 1.23; 95% confidence interval [95% CI], 1.0-1.5) more likely to test HIV-seropositive than clinic-based contacts. Relations between HIV test outcome and variables for client age, race, gender, previous testing history, mode of risk exposure, and region, as well as service setting, were examined by logistic regression. An inverted relation between service setting and seropositivity (OR, 0.65; 95% CI, 0.5-0.8) indicated that, within some subpopulations, outreach contacts were significantly less likely to test HIV-positive than clinic-based contacts. Analysis of interactions among the covariates identified race as a critical codeterminant in the relation between service setting and test outcome. These results support retargeting outreach services to enhance their overall effectiveness. Specific recommendations include the need for aggressive strategies to better "market" HIV counseling and testing to nonwhite populations, and to focus resources more selectively on gay/bisexual men of all races.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Behavior; Biology; Blacks; Clinic Activities; Correlation Studies; Counseling; Cultural Background; Delivery Of Health Care; Demographic Factors; Developed Countries; Diseases; Ethnic Groups; Examinations And Diagnoses; Health; Health Facilities; Hiv Infections; Hiv Serodiagnosis; Homosexuals; Laboratory Examinations And Diagnoses; North America; Northern America; Organization And Administration; Population; Population Characteristics; Program Activities; Program Design; Program Evaluation; Programs; Research Methodology; Research Report; Risk Factors; Sex Behavior; Statistical Studies; Studies; Target Population; United States; Viral Diseases; Whites; Wisconsin

Mesh:

Year:  1998        PMID: 9803971     DOI: 10.1097/00042560-199811010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  5 in total

1.  Using motivational interviewing in HIV field outreach with young African American men who have sex with men: a randomized clinical trial.

Authors:  Angulique Y Outlaw; Sylvie Naar-King; Jeffrey T Parsons; Monique Green-Jones; Heather Janisse; Elizabeth Secord
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

2.  Bringing testing to the people - benefits of mobile unit HIV/syphilis testing in Lima, Peru, 2007-2009.

Authors:  Mindy C Lipsitz; Eddy R Segura; José Luis Castro; Edward Smith; Carlos Medrano; Jesse L Clark; Jordan E Lake; Robinson Cabello
Journal:  Int J STD AIDS       Date:  2013-10-09       Impact factor: 1.359

3.  Validation of a single-platform, volumetric, flow cytometry for CD4 T cell count monitoring in therapeutic mobile unit.

Authors:  François-Xavier Mbopi-Kéou; Bertrand Sagnia; Jeanne Ngogang; Fru F Angwafo; Vittorio Colizzi; Luc Montagnier; Laurent Bélec
Journal:  J Transl Med       Date:  2012-02-06       Impact factor: 5.531

4.  Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.

Authors:  David R Holtgrave
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

Review 5.  Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches.

Authors:  Amitabh B Suthar; Nathan Ford; Pamela J Bachanas; Vincent J Wong; Jay S Rajan; Alex K Saltzman; Olawale Ajose; Ade O Fakoya; Reuben M Granich; Eyerusalem K Negussie; Rachel C Baggaley
Journal:  PLoS Med       Date:  2013-08-13       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.